Category: HealthSubscribe via RSS Feed

Swiss doctors urge COVID vulnerable to declare end-of-life wishes in advance

21-Nov-2020 Intellasia | Reuters | 10:59 AM

Swiss doctors have urged those vulnerable to COVID-19 complications to record their wishes for end-of-life care in advance to help ease pressure on intensive care units, [...] » More

Analysis: Can first COVID-19 vaccines bring herd immunity? Experts have doubts

19-Nov-2020 Intellasia | Reuters | 6:02 AM

Governments and officials are voicing hopes that COVID-19 vaccines could bring “herd immunity”, with some calculating that immunising just two-thirds of a [...] » More

Breakthrough COVID vaccine tech could help defeat other diseases

17-Nov-2020 Intellasia | Reuters | 10:00 AM

Breakthrough technology that transforms the body into a virus-zapping vaccine factory is poised to revolutionise the fight against COVID-19 but future pandemics and even [...] » More

Moderna vaccine is second to exceed expectations; mutated virus may be more vulnerable to new vaccines

17-Nov-2020 Intellasia | Reuters | 9:53 AM

The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by [...] » More

World should not be complacent after COVID-19 vaccine news-WHO

17-Nov-2020 Intellasia | Reuters | 9:52 AM

The World Health Organization (WHO) welcomed Moderna reporting on Monday that its experimental vaccine showed 94.5 percent efficacy but said that “many questions” [...] » More

WHO says it investigating potential cluster of COVID-19 cases among staff

17-Nov-2020 Intellasia | Reuters | 9:50 AM

The World Health Organization (WHO) said on Monday there had been 65 coronavirus infections among staff at its Geneva headquarters since the start of the pandemic and that a [...] » More

J&J starts two-dose trial of its COVID-19 vaccine candidate

17-Nov-2020 Intellasia | Reuters | 7:16 AM

Johnson & Johnson launched a new large-scale late-stage trial on Monday to test a two-dose regimen of its experimental COVID-19 vaccine and evaluate potential incremental [...] » More

Riskier blood thinner used more often in Black patients; psychiatric issues linked to COVID-19

13-Nov-2020 Intellasia | Reuters | 6:02 AM

The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by [...] » More

Vaccine innovation sparks hope, questions

11-Nov-2020 Intellasia | AFP | 9:06 AM

Reports that one of the vaccines for Covid-19 has shown highly promising results are a ray of hope for a world in the shadow of surging virus cases. But does it mean the [...] » More

We may soon have a COVID-19 vaccine. But will enough people take it?

11-Nov-2020 Intellasia | Reuters | 6:02 AM

With COVID-19 vaccine trial results looking positive, governments and pharmaceutical firms face their next daunting challenge: convincing the world to get inoculated. Public [...] » More

Pfiser, BioNTech initial vaccine results impress, but scientists remain cautious

11-Nov-2020 Intellasia | Reuters | 6:02 AM

Scientists on Monday said initial trial results for Pfiser Inc and BioNTech’s coronavirus vaccine far outpaced their expectations for protection against a completely [...] » More

One in five COVID-19 patients develop mental illness within 90 days-study

11-Nov-2020 Intellasia | Reuters | 6:02 AM

Many COVID-19 survivors are likely to be at greater risk of developing mental illness, psychiatrists said on Monday, after a large study found 20 percent of those infected [...] » More

Pfiser vaccine trial success signals breakthrough in pandemic battle

Pfiser vaccine trial success signals breakthrough in pandemic battle

11-Nov-2020 Intellasia | Reuters | 6:02 AM

Pfiser Inc’s PFE.N experimental COVID-19 vaccine is more than 90 percent effective based on initial trial results, the drugmaker said on Monday, a major victory in the [...] » More

Why Pfiser’s ultra-cold COVID-19 vaccine will not be at the local pharmacy any time soon

11-Nov-2020 Intellasia | Reuters | 6:02 AM

Work to distribute the experimental COVID-19 vaccine developed by Pfiser Inc and BioNTech SE is gearing up after the companies announced successful interim data earlier on [...] » More

English study suggests T cells could be sufficient to protect from COVID-19

11-Nov-2020 Intellasia | Reuters | 6:02 AM

High levels of so-called “T cells” that respond to the coronavirus could be sufficient to offer protection against infection, an English study said on Tuesday, [...] » More